SCHEMBL23610285

SCHEMBL23610285

COc1nc(C2CC2)c(F)cc1NS(=O)(=O)c1c[nH]c2cc(Cl)ccc12

nearest known ligand 0.43

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SGK1 O00141 8/20 0.43
NR4A2 P43354 1/20 0.39
CCR2 P41597 2/20 0.38
SLC40A1 Q9NP59 1/20 0.38
EIF2AK4 Q9P2K8 3/20 0.37
CYP1A2 P05177 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP3A4 P08684 2/20 0.36
EIF2AK3 Q9NZJ5 2/20 0.36
PI4KB Q9UBF8 1/20 0.36
PIK3CA P42336 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29829649 1.00 SGK1 (0.43) SGK1NR4A2CCR2SLC40A1EIF2AK4
SCHEMBL21596684 0.89 NR4A2 (0.42) SGK1NR4A2CCR2SLC40A1EIF2AK4
SCHEMBL29829588 0.89 NR4A2 (0.42) SGK1NR4A2CCR2SLC40A1EIF2AK4
SCHEMBL21596666 0.89 SGK1 (0.39) SGK1EIF2AK4CYP1A2CYP3A4EIF2AK3
SCHEMBL21596705 0.88 NR4A2 (0.43) SGK1NR4A2CCR2SLC40A1EIF2AK4
SCHEMBL29829570 0.88 NR4A2 (0.43) SGK1NR4A2CCR2SLC40A1EIF2AK4
SCHEMBL23610281 0.88 SGK1 (0.46) SGK1CCR2SLC40A1CYP1A2
SCHEMBL29830171 0.88 SGK1 (0.46) SGK1CCR2SLC40A1CYP1A2
SCHEMBL21596656 0.86 SGK1 (0.40) SGK1NR4A2CCR2SLC40A1EIF2AK4
SCHEMBL21596672 0.84 SGK1 (0.42) SGK1NR4A2CCR2SLC40A1EIF2AK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112469710-B Pyridyl and pyrazinyl- (aza) indole sulfonamides 优时比制药有限公司 2024-05-14 CN claimed
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 US claimed
EP-3810591-B1 PYRIDINYL AND PYRAZINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2022-08-10 EP claimed
US-20210206749-A1 Pyridinyl and Pyrazinyl-(Asa)Indolsulfonamides UCB PHARMA GMBH (DE) 2021-07-08 US claimed
CN-112469710-A Pyridyl and pyrazinyl- (aza) indole sulfonamides 优时比制药有限公司 2021-03-09 CN claimed
CN-112469710-B Pyridyl and pyrazinyl- (aza) indole sulfonamides 优时比制药有限公司 2024-05-14 CN disclosed
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 US disclosed
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 US disclosed
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 US disclosed
EP-4074703-B1 PYRIDINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2023-11-29 EP disclosed
EP-4074703-A1 PYRIDINYL-(AZA)INDOLSULFONAMIDES UCB Pharma GmbH (DE) 2022-10-19 EP disclosed
EP-3810591-B1 PYRIDINYL AND PYRAZINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2022-08-10 EP disclosed
US-20210206749-A1 Pyridinyl and Pyrazinyl-(Asa)Indolsulfonamides UCB PHARMA GMBH (DE) 2021-07-08 US disclosed
US-20210206749-A1 Pyridinyl and Pyrazinyl-(Asa)Indolsulfonamides UCB PHARMA GMBH (DE) 2021-07-08 US disclosed
CN-112469710-A Pyridyl and pyrazinyl- (aza) indole sulfonamides 优时比制药有限公司 2021-03-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210206749-A1 Pyridinyl and Pyrazinyl-(Asa)Indolsulfonamides GPR17, GPR18, GPR119 SGK1 1683/4885NR4A2 271/4885CCR2 916/4885
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides GPR17, GPR18, GPR119 SGK1 1683/4885NR4A2 271/4885CCR2 916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.